<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02326012</url>
  </required_header>
  <id_info>
    <org_study_id>2014/1-31/3</org_study_id>
    <nct_id>NCT02326012</nct_id>
  </id_info>
  <brief_title>Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study</brief_title>
  <official_title>Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim is to investigate the effectiveness of Emotion Regulation Individual Therapy
      for Adolescents (ERITA) who self-harm.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Deliberate Self-Harm Inventory - 9 item version</measure>
    <time_frame>Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in self-harming behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Borderline Symptom List Behavior supplement (BSL-supplement)</measure>
    <time_frame>Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in self-destructive and risky behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulties in Emotion Regulation Scale -16 item version (DERS-16)</measure>
    <time_frame>Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks and at 6 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diary questionnaire (DQ)</measure>
    <time_frame>Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks and at 6 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulties in Emotion Regulation Scale (DERS)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in difficulties in emotion regulation after 12 weeks and at 6 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strengths and Difficulties Questionnaire Child and Parent version (SDQ-C/P)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in strengths and difficulties after 12 weeks and at 6 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Borderline personality features in childhood (BPFS-C)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in borderline personality features after 12 weeks and at 6 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The alcohol use disorders identification test - C (AUDIT-C)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in alcohol use after 12 weeks and at 6 months after treatment has ended.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the Drug Use Disorders Identification Test - C (DUDIT-C)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from baseline in drug use after 12 weeks and at 6 months after treatment has ended.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Euroqol-5D (EQ-5D)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from Baseline in quality of life after 14 weeks and at 6- and 12 months after treatment has Change from baseline in quality of life after 12 weeks and at 6 months after treatment has ended. Used for health economic evaluations.</description>
  </other_outcome>
  <other_outcome>
    <measure>Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness - Child version (TiC-P)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change from Baseline in societal costs after 14 weeks and at 6- and 12 months after treatment has Change from baseline in quality of life after 12 weeks and at 6 months after treatment has ended. Used for health economic evaluations.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Health Questionnaire (PHQ9)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change in patient parent health from baseline after 12 weeks and at 6 months after treatment has ended.</description>
  </other_outcome>
  <other_outcome>
    <measure>General Anxiety Disorder (GAD7)</measure>
    <time_frame>Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up</time_frame>
    <description>Change in patient parent health from baseline after 12 weeks and at 6 months after treatment has ended.</description>
  </other_outcome>
  <other_outcome>
    <measure>The treatment credibility scale</measure>
    <time_frame>One week after treatment start</time_frame>
    <description>Perceived treatment credibility</description>
  </other_outcome>
  <other_outcome>
    <measure>Working Alliance Inventory (WAI) short version</measure>
    <time_frame>Three weeks after treatment start</time_frame>
    <description>Perceived working alliance</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Nonsuicidal Self-Injury</condition>
  <arm_group>
    <arm_group_label>Emotion Regulation Individual Therapy for Adolescents</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Emotion Regulation Individual Therapy for Adolescents</intervention_name>
    <arm_group_label>Emotion Regulation Individual Therapy for Adolescents</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a primary diagnosis of NSSI as defined by DSM-5 Section 3

          -  &lt; 1 NSSI episode during the past month

          -  at least one parent needs to commit to participate in the parent program

        Exclusion Criteria:

          -  bipolar disorder I or primary psychosis

          -  severe suicidal ideation

          -  ongoing substance dependence

          -  Insertion/withdrawal of psychopharmacological substances within two months prior to
             the treatment

          -  other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in
             first hand

          -  current life circumstances that would hinder the treatment (i.e. ongoing domestic
             abuse)

          -  insufficient Swedish language skills

          -  Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral
             therapy (DBT)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Karolinska Institutet</name>
      <address>
        <city>Stockholm</city>
        <zip>113 64</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2014</study_first_submitted>
  <study_first_submitted_qc>December 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 25, 2014</study_first_posted>
  <last_update_submitted>January 3, 2016</last_update_submitted>
  <last_update_submitted_qc>January 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Clara Hellner Gumpert</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Self-Injurious Behavior</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

